Company intelligence / Profile preview

Lucina BioSciences

Aurora, Colorado, United Stateslucina.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Lucina BioSciences develops, manufactures, and distributes novel placental-derived allograft products using its proprietary Nativus® Processing System. The company focuses on maintaining the natural properties of human placental tissues to enhance patient wellness. Their solutions are used in wound care, orthopedics, ophthalmology, and other areas requiring advanced biologic grafts. They operate under strict GMP/FDA compliance with a focus on quality management.

Therapeutic areas: OtherDermatologyOphthalmology
Modalities: Placental-derived allograft products (Biologic)Tissue-based therapies (Biologic)Allograft products (Biologic)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Lucina BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lucina BioSciences.

Explore the full profile